default author photo

Ivis Mendoza-Hernández

National Coordinating Center for Clinical Trials

SCHOLARLY PAPERS

3

DOWNLOADS

243

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Safety and Immunogenicity of Anti-SARS Cov-2 Vaccine SOBERANA 02 in Homologous or Heterologous Scheme

Number of pages: 19 Posted: 03 Dec 2021
Instituto de Medicina Tropical Pedro Kouri, affiliation not provided to SSRN, Finlay Vaccine Institute, Finlay Vaccine Institute, Institute of Cybernetics, Mathematics and Physics (ICIMAF), Finlay Vaccine Institute, Center of Molecular Immunology, Finlay Vaccine Institute, Finlay Vaccine Institute, Center of Molecular Immunology, affiliation not provided to SSRN, affiliation not provided to SSRN, Civilian Defense Scientific Research Centre, Civilian Defense Scientific Research Centre, affiliation not provided to SSRN, Immunoassay Center, affiliation not provided to SSRN, National Coordinating Center for Clinical Trials, Finlay Vaccine Institute, Finlay Vaccine Institute, Finlay Vaccine Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Sichuan University, Center of Molecular Immunology, affiliation not provided to SSRN, affiliation not provided to SSRN, Finlay Vaccine Institute, Finlay Vaccine Institute, Finlay Vaccine Institute and affiliation not provided to SSRN
Downloads 120 (596,393)

Abstract:

Loading...

COVID-19, SARS-CoV-2, conjugate vaccine, heterologous immunization scheme, subunit vaccine

2.

Safety and Efficacy of the Two Doses Conjugated Protein-Based SOBERANA-02 COVID-19 Vaccine and of a Heterologous Three-Dose Combination with SOBERANA-PLUS: Double-Blind, Randomised, Placebo-Controlled Phase 3 Clinical Trial

Number of pages: 24 Posted: 27 Jul 2022
Instituto de Medicina Tropical Pedro Kouri, Havana Hygiene and Epidemiology Center, Institute of Cybernetics, Mathematics and Physics (ICIMAF), Instituto de Medicina Tropical Pedro Kouri, Instituto de Medicina Tropical Pedro Kouri, Finlay Vaccine Institute, Finlay Vaccine Institute, National Coordinating Center for Clinical Trials, Finlay Vaccine Institute, “José Antonio Echevarría” Technological University, UCT Geocuba Research and Consulting, UCT Geocuba Research and Consulting, Finlay Vaccine Institute, Instituto de Medicina Tropical Pedro Kouri, Instituto de Medicina Tropical Pedro Kouri, Finlay Vaccine Institute, Havana Hygiene and Epidemiology Center, Municipal Health Department, Centro Habana, Municipal Health Department, La Lisa, Municipal Health Department, 10 de Octubre, Municipal Health Department, Habana Vieja, Municipal Health Department, Cerro, Municipal Health Department, Marianao, Municipal Health Department, Plaza Havana, Municipal Health Department, Plaza Havana, Pasteur Institute of Iran, Iran University of Medical Sciences, Pasteur Institute of Iran, Ghent University - Faculty of Medicine and Health Sciences, Finlay Vaccine Institute, Finlay Vaccine Institute, Finlay Vaccine Institute, Finlay Vaccine Institute and Finlay Vaccine Institute
Downloads 93 (725,554)

Abstract:

Loading...

conjugate-vaccine, SARS-COV-2, COVID-19 Vaccine, heterologous scheme, RBD-subunit vaccine, vaccine efficacy

3.

Safety and Immunogenicity of Anti-SARS-CoV-2 Conjugate Vaccine SOBERANA 02: Phase IIb Clinical Trial

Number of pages: 56 Posted: 01 Feb 2022
Instituto de Medicina Tropical Pedro Kouri, Havana Hygiene and Epidemiology Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Finlay Vaccine Institute, affiliation not provided to SSRN, Finlay Vaccine Institute, Center of Molecular Immunology, Finlay Vaccine Institute, Center of Molecular Immunology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Civilian Defense Scientific Research Centre, Immunoassay Center, affiliation not provided to SSRN, National Coordinating Center for Clinical Trials, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Finlay Vaccine Institute, Finlay Vaccine Institute, affiliation not provided to SSRN, Finlay Vaccine Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, Pasteur Institute of Iran, Pasteur Institute of Iran, affiliation not provided to SSRN, Finlay Vaccine Institute, affiliation not provided to SSRN, Finlay Vaccine Institute, Finlay Vaccine Institute and Independent
Downloads 30 (1,318,317)

Abstract:

Loading...

conjugate vaccine, heterologous schedule, COVID-19, recombinant RBD, phase IIb clinical trial